Executive record

Andrea Heslin Smiley

Director at AtaiBeckley Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:andrea-heslin-smileyVersion: public-0As of: 2026-09-28

Not yet claimed12 published Claims6 sources
  • Director

Key Claims

Biography

Andrea Heslin Smiley has been a director since December 2020. She currently serves as President and CEO of Momentum Life Sciences, a provider of clinical educator solutions. She has more than 25 years of commercialization and management experience in the biopharmaceutical industry in both public and private companies, including executive positions at Eli Lilly and Company.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Executive career

  1. Dates not publishedExecutive title: President and Chief Executive Officer · Organization not publishedRMTI DEF 14A director slate

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

6 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. ATAI DEF 14A director slate

    sec filing · Source published: Apr 21, 2025 · Retrieved: May 15, 2026

    Supports 2 claims
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Audit · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Apr 21, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at AtaiBeckley Inc. · Claim reviewed: May 16, 2026

  3. RMTI DEF 14A director slate

    sec filing · Source published: Apr 14, 2025 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Compensation, Nominating/Governance · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Momentum Life Sciences · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  4. Open source

    sec proxy · Source published: Apr 14, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at ROCKWELL MEDICAL, INC. · Claim reviewed: May 16, 2026

  5. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of AtaiBeckley Inc. · Claim reviewed: May 16, 2026

  6. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of ROCKWELL MEDICAL, INC. · Claim reviewed: May 16, 2026